发明公开
- 专利标题: Therapeutic uses of BR43X2 soluble receptors
- 专利标题(中): BR43X2可溶性受体的治疗用途
-
申请号: EP05018984.4申请日: 2000-01-07
-
公开(公告)号: EP1642972A1公开(公告)日: 2006-04-05
- 发明人: Gross, Jane A. , Xu, Wenfeng , Madden, Karen , Yee, David P.
- 申请人: ZymoGenetics, Inc.
- 申请人地址: 1201 Eastlake Avenue East Seattle, WA 98102 US
- 专利权人: ZymoGenetics, Inc.
- 当前专利权人: ZymoGenetics, Inc.
- 当前专利权人地址: 1201 Eastlake Avenue East Seattle, WA 98102 US
- 代理机构: MacLean, Martin Robert
- 优先权: US226533 19990107
- 主分类号: C12N15/11
- IPC分类号: C12N15/11 ; C07K14/705 ; A61K38/17 ; A61K39/395
摘要:
Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.
公开/授权文献
- EP1642972B1 Therapeutic uses of BR43X2 soluble receptors 公开/授权日:2009-12-30
信息查询
IPC分类: